- Home
- ST vs LNTH Comparison
ST vs LNTH Comparison
Compare ST & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ST
- LNTH
- Stock Information
- Founded
- ST 1916
- LNTH 1956
- Country
- ST United States
- LNTH United States
- Employees
- ST N/A
- LNTH N/A
- Industry
- ST Industrial Machinery/Components
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ST Industrials
- LNTH Health Care
- Exchange
- ST Nasdaq
- LNTH Nasdaq
- Market Cap
- ST 5.3B
- LNTH 6.0B
- IPO Year
- ST 2010
- LNTH 2015
- Fundamental
- Price
- ST $29.49
- LNTH $78.23
- Analyst Decision
- ST Buy
- LNTH Strong Buy
- Analyst Count
- ST 13
- LNTH 6
- Target Price
- ST $39.08
- LNTH $132.67
- AVG Volume (30 Days)
- ST 2.0M
- LNTH 832.8K
- Earning Date
- ST 02-11-2025
- LNTH 02-26-2025
- Dividend Yield
- ST 1.63%
- LNTH N/A
- EPS Growth
- ST N/A
- LNTH 304.57
- EPS
- ST 0.85
- LNTH 6.02
- Revenue
- ST $3,932,764,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- ST N/A
- LNTH $19.64
- Revenue Next Year
- ST $5.38
- LNTH $5.16
- P/E Ratio
- ST $34.62
- LNTH $12.99
- Revenue Growth
- ST N/A
- LNTH 24.15
- 52 Week Low
- ST $24.91
- LNTH $56.44
- 52 Week High
- ST $43.14
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ST 61.75
- LNTH 31.32
- Support Level
- ST $25.42
- LNTH $79.39
- Resistance Level
- ST $30.28
- LNTH $84.24
- Average True Range (ATR)
- ST 0.92
- LNTH 3.84
- MACD
- ST 0.46
- LNTH -0.93
- Stochastic Oscillator
- ST 85.29
- LNTH 0.66
About ST Sensata Technologies Holding plc
Sensata Technologies is a global supplier of sensors for transportation and industrial applications. Sensata sells a bevy of pressure, temperature, force, and position sensors into the automotive, heavy vehicle, industrial, heating, ventilation, and cooling, and aerospace markets. The majority of the firm's revenue comes from the automotive market, where it focuses on bumper-in applications.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.